FONT-SIZE Plus   Neg

Zimmer Receives FDA Nod To Market IASSIST Knee - Quick Facts

Zimmer Holdings, Inc. (ZMH), announced Thursday that it has received a 510(k) clearance from the U.S. Food and Drug Administration or FDA, enabling it to market iASSIST Knee, the company's personalized guidance system for knee replacement procedures.

The iASSIST Knee technology which comprises small electronic disposable pod components, provides accurate alignment validation through an electronic display, at the site of the knee replacement surgery.

The technology enables surgeons to easily perform joint replacement procedures as the iASSIST Knee technology provides accurate intraoperative feedback required for such procedures, said Zimmer in a statement.

Jeff McCaulley, President of Zimmer Reconstructive stated, "This technology supports more streamlined and personalized knee replacement procedures through a simple, disposable intraoperative device and delivers accurate implant positioning and alignment validation without the complexity, cost and time associated with current intensive navigation and robotic systems."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Boeing Co. (BA) reported a profit for the third-quarter climbed 34 percent from the the previous year, reflecting overall solid execution on production programs and services, favorable tax items, and timing of aircraft deliveries. The company raised its 2016 financial and delivery guidance reflecting higher commercial deliveries and the impact of the tax basis adjustment. GlaxoSmithKline PLC (GSK.L, GSK) reported that its third-quarter core operating profit was 2.32 billion pounds, 13% higher in CER terms than in prior year. Core earnings per share for the quarter was up 12% CER to 32.0 pence. Total basic earnings per share was 16.6 pence, down 1% CER, primarily reflecting... Coca-Cola Co. (KO) reported a profit for the third-quarter that declined 28 percent from the prior year. Net revenues were down 7% from prior year, impacted by a foreign currency exchange headwind of 2% and a headwind from acquisitions, divestitures and structural items of 8%. The company reaffirmed organic revenue and comparable earnings per share outlook for fiscal year 2016.
comments powered by Disqus
Follow RTT